Probiotics Reduce Inflammation in Antiretroviral Treated, HIV-Infected Individuals: Results of the “Probio-HIV” Clinical Trial

• Gabriella d’Ettorre,

  Affiliation Department of Public Health and Infectious Diseases, University of Rome “Sapienza”, Rome, Italy

  ⨯
• Giancarlo Ceccarelli ,

  * E-mail: giancarlo.ceccarelli@uniroma1.it

  Affiliation Department of Public Health and Infectious Diseases, University of Rome “Sapienza”, Rome, Italy

  ⨯
• Noemi Giustini,

  Affiliation Department of Public Health and Infectious Diseases, University of Rome “Sapienza”, Rome, Italy

  ⨯
• Sara Serafino,

  Affiliation Department of Public Health and Infectious Diseases, University of Rome “Sapienza”, Rome, Italy

  ⨯
• Nina Calantone,

  Affiliation Program in Barrier Immunity and Repair, Lab of Molecular Microbiology, NIAID, NIH, Bethesda, Maryland, United States of America

  ⨯
• Gabriella De Girolamo,

  Affiliation Department of Public Health and Infectious Diseases, University of Rome “Sapienza”, Rome, Italy

  ⨯
• Luigi Bianchi,

  Affiliation Department of Public Health and Infectious Diseases, University of Rome “Sapienza”, Rome, Italy

  ⨯
• Valeria Bellelli,

  Affiliation Department of Public Health and Infectious Diseases, University of Rome “Sapienza”, Rome, Italy

  ⨯
• Tommaso Ascoli-Bartoli,

  Affiliation Department of Public Health and Infectious Diseases, University of Rome “Sapienza”, Rome, Italy

  ⨯
• Sonia Marcellini,

  Affiliation Department of Public Health and Infectious Diseases, University of Rome “Sapienza”, Rome, Italy

  ⨯
• Ombretta Turriziani,

  Affiliation Department of Virology, University of Rome “Sapienza”, Rome, Italy

  ⨯
• Jason M. Brenchley,

  Affiliation Program in Barrier Immunity and Repair, Lab of Molecular Microbiology, NIAID, NIH, Bethesda, Maryland, United States of America

  ⨯
• Vincenzo Vullo

  Affiliation Department of Public Health and Infectious Diseases, University of Rome “Sapienza”, Rome, Italy

  ⨯